Rising Pharma
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Rising Pharma and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-07-29FDA-DrugClass IIRising Cyproheptadine Hydrochloride Syrup recalled for precipitate
Rising Pharma's Cyproheptadine Hydrochloride Syrup (2 mg/5 mL, 473 mL bottles) is being recalled because the medication is crystallizing and forming particles that float in the bottle. This affects specific batches distributed nationwide. No injuries have been reported.
- 2026-03-11FDA-DrugClass IIStop using Rising Pharma Temozolomide capsules
Rising Pharmaceuticals is recalling specific bottles of Temozolomide 5mg capsules because testing found the medication didn't meet quality standards for purity and stability. The issue was discovered during routine 9-month stability testing. This affects 1,200 bottles distributed nationwide with expiration date 09/2026.
Get notified about new Rising Pharma recalls
Free weekly digest. We email when a new federal recall affects Rising Pharma or anything else in your household.
Get the Sunday Brief